dr. Luís Filipe Abreu de Carvalho (MD)

HPB surgeon, Department of Hepatopancreatobiliary Surgery and Liver Transplantation, UZ Gent
Doctoral fellow - Department of Human Structure and Repair (UGent)
Principal investigator: prof. Frederik Berrevoet (MD, PhD)
Research focus
My research is dedicated to enhancing the understanding and treatment of borderline and locally advanced pancreatic cancer. By leveraging multi-Omics analysis — encompassing genomics, proteomics, and radiomics — we aim to refine the evaluation of response to neoadjuvant chemotherapy. This comprehensive approach seeks to:
Improve disease characterization for better risk stratification
Enhance the assessment of treatment responses and prognostic outcomes
Develop more effective treatment algorithms tailored to individual patient profiles, leading to personalized therapeutic strategies
Additionally, my work focuses on optimizing minimally invasive liver surgery for treating metastatic and primary hepatobiliary cancers. Utilizing advanced techniques such as 3D-models, video analysis, and liver function studies, our objectives are to:
Increase precision in preoperative diagnosis
Improve intra-operative visualization and surgical techniques
Enhance oncological outcomes by maximizing efficiency and effectiveness in the surgical setting
Our goal is to push the boundaries of cancer treatment, ultimately improving patient outcomes and advancing the field of oncological surgery.
Biography
Luís Carvalho is a Hepatopancreatobiliary surgeon at Ghent University Hospital. He graduated from the University of Lisbon (Portugal) in 2008 after which he followed his surgical training at Ghent University Hospital and associated hospitals in Ghent. The surgical training was completed in 2015. In recognition for his work, he received the Young Investigator’s Award at the 16th Belgian Surgical Week in 2015.
Dr. Carvalho specialized further in hepatopancreatobiliary surgery with fellowships at Lille University Hospital (France) and Leuven Catholic University. In 2018, he obtained the European Board of Surgery qualification in Hepatopancreatobiliary surgery in Geneva, Switzerland.
Dr. Carvalho continues to advance in the field of hepatopancreatobiliary surgery with his commitment to innovative surgical practices and research. He is a member of the editorial board of Acta Chirurgica Belgica.
Key publications
- ‘Predictive factors for survival in borderline resectable and locally advanced pancreatic cancer: are these really two different entities?’ BMC Surgery, 2023. (PMID: 37775737)
- ‘The Role of Donor Gamma-Glutamyl Transferase as a Risk Factor for Early Graft Function after Liver Transplantation’. Journal Clinical Medicine, 2023. (PMID: 37510859)
- ‘Effect of norepinephrine infusion on hepatic blood flow and its interaction with somatostatin: an observational cohort study’. BMC Anesthesiology, 2022. (PMID: 35780092)
- ‘Liver resection and ablation for squamous cell carcinoma liver metastases’. British Journal of Surgery Open, 2021. (PMID: 34426830)
- Local control of hepatocellular carcinoma and colorectal liver metastases after surgical microwave ablation without concomitant hepatectomy’. Langenbecks Archives Surgery, 2021. (PMID: 34076718)
Contact & links
- Lab address: Campus UZ Gent, entrance 12, route 1325
- Luís Filipe Abreu de Carvalho is involved in the European Organisation for Research and Treatment of Cancer (EORTC)
- Luís Filipe Abreu de Carvalho is interested to receive invitations for presentations or talks